General / Eligibility

Roll Up Your Sleeves Miami Roll Up Your Sleeves Miami

How many doses will the University be receiving? Will there be enough of the vaccine for everyone that wants to get vaccinated?

  • We do know there will not be enough vaccine at the beginning of the on-campus vaccination process to meet the demand of all individuals who would like to be vaccinated. We expect sufficient doses to be available to vaccinate our student, staff, and faculty before fall.
  • Once we are able to vaccinate the majority of our faculty and staff, we will then begin students.

How many different vaccines are available? Which vaccine(s) are we using?

  • There are multiple vaccine candidates currently undergoing clinical trials. Pfizer and Moderna have received Emergency Use Authorization (EUA). 
  • The Ohio Department of Health is ultimately responsible for determining which vaccines are allocated to each distribution site, including TriHealth. 

Who is eligible to receive the vaccine?

  • Prioritization is guided by general principles and requirements set forth by federal and state governments. Those who work in situations where the risk of contracting COVID-19 infection is higher, such as teaching face-to-face or working in dining and residence halls, will receive priority. This includes those directly caring for COVID-19 students or cleaning areas where COVID-19 students are isolated or quarantined.
  • Employees will be notified by email when they are able to schedule an appointment to receive the vaccine.

Who determined the criteria?

  • The CDC’s Advisory Committee on Immunization Practices (ACIP) develops the national recommendations on the use of vaccines. As these are new vaccines, production will need to ramp up to meet demand. The National Academies of Sciences, Engineering and Medicine’s Committee on Equitable Allocation of Vaccine created the suggested framework for distribution. This work was sponsored (funded) by the National Institutes of Health and the Centers for Disease Control and Prevention (CDC).
  • The Ohio Department of Health has been meeting weekly since mid-August to strategize vaccine distribution for our state.

How does the vaccine work to protect you against COVID-19?

  • Both Pfizer and Moderna are manufacturing a vaccine using messenger ribonucleic acid (mRNA). mRNA is naturally found in humans; its role is to deliver instructions from DNA to cells about which proteins the cell needs to create.
  • The SARS-CoV-2 coronavirus contains spike proteins (S protein) that penetrate and infect healthy cells in the body. The vaccines use mRNA that mirrors the genetic code of SARS-CoV-2 spike proteins to convince the recipient’s immune system to develop antibodies to the SARS-CoV-2 protein. Those antibodies are then able to recognize the SARS-CoV-2 virus if the recipient comes into contact with the virus and can more effectively clear the virus from the body and prevent severe infection.